Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin

Morris Sherman; Lawrence Cohen; Mary Anne Cooper; Magdy Elkashab; Victor Feinman; David Fletcher; Nigel Girgrah; Jenny Heathcote; Mark Levstik; William B McNaull; David Wong; Florence Wong; Colina Yim

doi:10.1155/2006/497059

Canadian Journal of Gastroenterology (Jan 2006)

Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin

Morris Sherman,
Lawrence Cohen,
Mary Anne Cooper,
Magdy Elkashab,
Victor Feinman,
David Fletcher,
Nigel Girgrah,
Jenny Heathcote,
Mark Levstik,
William B McNaull,
David Wong,
Florence Wong,
Colina Yim

Affiliations

Morris Sherman: Toronto General Hospital, University of Toronto, Canada
Lawrence Cohen: Sunnybrook and Women’s College Health Sciences Centre and Faculty of Medicine, University of Toronto, Canada
Mary Anne Cooper: Sunnybrook and Women’s College Health Sciences Centre and Faculty of Medicine, University of Toronto, Canada
Magdy Elkashab: North York General Hospital, University of Toronto, Canada
Victor Feinman: Mount Sinai Hospital and Faculty of Medicine, University of Toronto, Canada
David Fletcher: Maple Leaf Medical Clinic, University of Toronto, Toronto, Canada
Nigel Girgrah: Toronto General Hospital, University of Toronto, Canada
Jenny Heathcote: Toronto Western Hospital and Faculty of Medicine, University of Toronto, Toronto, Canada
Mark Levstik: London Health Sciences Centre and Schulich School of Medicine, University of Western Ontario, London, Ontario, Canada
William B McNaull: Mount Sinai Hospital and Faculty of Medicine, University of Toronto, Canada
David Wong: Toronto Western Hospital and Faculty of Medicine, University of Toronto, Toronto, Canada
Florence Wong: Toronto General Hospital, University of Toronto, Canada
Colina Yim: Toronto Western Hospital and Faculty of Medicine, University of Toronto, Toronto, Canada

DOI: https://doi.org/10.1155/2006/497059
Journal volume & issue: Vol. 20, no. 7
pp. 479 – 485

Abstract

Read online

Today, combination antiviral therapy with pegylated interferon-alpha and ribavirin (RBV) allows many patients infected with hepatitis C virus (HCV) to achieve a sustained virological response, which is equivalent to cure. Data also support the clinical benefit of combination antiviral therapy in patients coinfected with HCV and HIV, and in patients who have received a liver transplant.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal